ProfileGDS4718 / 243740_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 8% 1% 37% 5% 11% 27% 22% 3% 4% 7% 17% 11% 15% 26% 23% 8% 20% 12% 16% 1% 4% 8% 12% 8% 11% 19% 24% 19% 11% 22% 15% 14% 6% 13% 17% 18% 31% 3% 6% 42% 10% 19% 16% 45% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.726378
GSM549102patient 115, normal, homogenized [OPG study]3.340581
GSM549104patient 119, normal, homogenized [OPG study]4.8302637
GSM549108patient 138, normal, homogenized [OPG study]3.586965
GSM549119patient 077, normal, homogenized [OPG study]3.808111
GSM549133patient 032, cancer, homogenized [OPG study]4.3623927
GSM549139patient 042, cancer, homogenized [OPG study]4.2055322
GSM549099patient 107, normal, homogenized [OPG study]3.479233
GSM549109patient 139, normal, homogenized [OPG study]3.583184
GSM549110patient 046, normal, homogenized [OPG study]3.656277
GSM549114patient 063, normal, homogenized [OPG study]3.9987917
GSM549122patient 082, normal, homogenized [OPG study]3.831311
GSM549134patient 033, cancer, homogenized [OPG study]3.9405415
GSM549136patient 036, cancer, homogenized [OPG study]4.3232626
GSM549140patient 044, cancer, homogenized [OPG study]4.2122323
GSM549111patient 047, normal, homogenized [OPG study]3.677338
GSM549113patient 057, normal, homogenized [OPG study]4.0884220
GSM549132patient 031, cancer, homogenized [OPG study]3.8349212
GSM549137patient 038, cancer, homogenized [OPG study]3.9768316
GSM549142patient 047, cancer, homogenized [OPG study]3.404521
GSM549100patient 110, normal, homogenized [OPG study]3.537074
GSM549107patient 135, normal, homogenized [OPG study]3.687218
GSM549115patient 068, normal, homogenized [OPG study]3.8057712
GSM549116patient 072, normal, homogenized [OPG study]3.706088
GSM549120patient 078, normal, homogenized [OPG study]3.8214311
GSM549131patient 030, cancer, homogenized [OPG study]4.0565819
GSM549118patient 074, normal, homogenized [OPG study]4.2967724
GSM549129patient 027, cancer, homogenized [OPG study]4.1100419
GSM549123patient 088, normal, homogenized [OPG study]3.8234211
GSM549124patient 006, cancer, homogenized [OPG study]4.2738322
GSM549126patient 015, cancer, homogenized [OPG study]3.953215
GSM549128patient 025, cancer, homogenized [OPG study]3.9078414
GSM549103patient 117, normal, homogenized [OPG study]3.658956
GSM549117patient 073, normal, homogenized [OPG study]3.8913
GSM549138patient 041, cancer, homogenized [OPG study]4.0020717
GSM549141patient 045, cancer, homogenized [OPG study]4.0043918
GSM549130patient 028, cancer, homogenized [OPG study]4.6009931
GSM549101patient 111, normal, homogenized [OPG study]3.467643
GSM549105patient 128, normal, homogenized [OPG study]3.617646
GSM549106patient 134, normal, homogenized [OPG study]5.0194642
GSM549112patient 048, normal, homogenized [OPG study]3.7712510
GSM549125patient 011, cancer, homogenized [OPG study]4.1304919
GSM549127patient 024, cancer, homogenized [OPG study]3.9885516
GSM549135patient 035, cancer, homogenized [OPG study]5.2213545